Hasil Pencarian  ::  Simpan CSV :: Kembali

"Apoteker merupakan salah satu tenaga kesehatan yang memiliki tugas dan tanggung jawab serta perannya sangat dibutuhkan dalam pengelolaan obat baik dalam rangka produksi maupun pelayanan kepada masyarakat luas. Pelayanan kefarmasian untuk masyarakat secara langsung dapat dilakukan di apotek, rumah sakit, maupun puskesmas. Sedangkan dalam rangka melakukan pengembangan serta produksi obat dengan kualitas yang telah terstandar dapat dilakukan di industri farmasi. Bertujuan agar terlatihnya calon apoteker dalam melakukan tugas kefarmasian serta meningkatkan pemahaman terhadap peran, fungsi, posisi, dan tanggung jawab apoteker sehingga diperlukan praktik langsung di lapangan dengan melakukan Praktik Kerja Profesi Apoteker. Praktik Kerja dilakukan bertempa di Apotek Roxy Klender selama periode Februari 2022 dan PT. Soho Industri Pharmasi selama periode Maret – April 2022. Dengan dilakukannya praktik kerja diharapkan apoteker dapat mengetahui tugas serta tanggung jawabnya baik secara langsung maupun tidak langsung kepada masyarakat luas.

---

Pharmacists are one of the health workers who have duties and responsibilities and their role is very much needed in the management of drugs both in the context of production and service to the wider community. Pharmaceutical services for the community can be directly carried out at pharmacies, hospitals, and health centers. Meanwhile, in order to develop and produce drugs with standardized quality, it can be done in the pharmaceutical industry. The aim is to train prospective pharmacists in carrying out pharmaceutical duties and increase understanding of the roles, functions, positions, and responsibilities of pharmacists so that direct practice is needed in the field by conducting Pharmacist Professional Work Practices. Work Practices are carried out at the Roxy Klender Pharmacy during the period of February 2022 and PT. Soho Pharmasi Industry during the period March – April 2022. By doing the work practice, it is hoped that pharmacists can know their duties and responsibilities both directly and indirectly to the wider community."

"Piroksikam merupakan obat non steroid antiinflamasi dengan efek antipiretik dan analgesik. Obat digolongkan ke dalam sistem BCS (Biopharmaceutical Classification System) kelas II yang memiliki tingkat kelarutan rendah namun permeabilitas tinggi. Pada penggunaannya, obat ini memiliki efek samping dapat mengiritasi mukosa gastrik. Untuk mengatasi permasalahan ini, penelitian bertujuan untuk memformulasikan piroksikam dalam bentuk mikroemulsi dengan minyak pembawa virgin coconut oil dan palm oil yang diadministrasikan secara transdermal. Pada penelitian, dilihat kumulatif obat terpenetrasi secara in vitro dengan sel difusi Franz menggunakan membran kulit abdomen tikus betina galur sprague-dawley. Formulasi mikroemulsi yang digunakan ialah minyak kelapa sawit (palm oil) atau virgin coconut oil, etanol 96% sebagai kosurfaktan, span 80 serta tween 80 sebagai surfaktan, propilparaben dan metilparaben sebagai antimikroba, dan butylated hydroxytoluen sebagai antioksidan. Evaluasi dilakukan dengan pengukuran globul sediaan, tegangan permukaan, pH, viskositas, bobot jenis, pengamatan uji stabilitas fisik pada suhu 40±2oC, 28±2oC, dan 4±2oC, cycling test, dan uji sentrifugasi. Uji penetrasi obat kumulatif terpenetrasi pada formulasi virgin coconut oil adalah 2469,037 ± 41,483 μg/cm2 dan jumlah fluks sebesar 4,317 ± 71,845 μg/cm2.jam dengan persentase kadar sebesar 55,347% sedangkan, pada formulasi palm oil sebesar 2030,907 ± 37,713 μg/cm2 dan jumlah fluks sebesar 3,498 ± 67,363 μg/cm2.jam dengan persentase kadar sebesar 40,881%. Berdasarkan hasil penelitian dapat disimpulkan bahwa mikroemulsi yang dihasilkan jernih dan stabil. Pada hasil uji penetrasi obat kumulatif, tingkat penetrasi mikroemulsi dengan pembawa virgin coconut oil memberikan jumlah penetrasi zat aktif lebih banyak dibandingkan mikroemulsi dengan pembawa palm oil.

---

Piroxicam is a non-steroidal anti-inflammatory drug with antipyretic and analgesic effects. Drugs are classified into the BCS (Biopharmaceutical Classification System) class II system which has low solubility but high permeability. Piroxicam has side effect can irritate the gastric mucosa. To overcome this problem, the aim of the study is to formulate piroxicam in the form of microemulsion with carrier of virgin coconut oil and palm oil which administered transdermally. In this study, the calculation of cumulative drug penetrated done by in vitro with Franz diffusion cells using the skin abdominal membrane of female sprague-dawley rats. The microemulsion formulations used were palm oil or virgin coconut oil, 96% ethanol as cosurfactant, span 80 and tween 80 as surfactants, propylparaben and methylparaben as antimicrobials agent, and butylated hydroxytoluene as antioxidants. Evaluation was carried out by measuring the globule of microemulsion, surface tension, pH, viscosity, specific gravity, observing physical stability tests at three different temperature of 40±2oC, 28±2oC, and 4±2oC, cycling test, and centrifugation mechanical stability test. The cumulative drug penetration test penetrated in the virgin coconut oil formulation was 2469,037 ± 41,483 μg/cm2 and the total flux was 4,317 ± 71,845 μg/cm2.hour with a percentage level of 55,347% while, in the palm oil formulation it was 2030, 907 ± 37,713 μg/cm2 and the amount of flux was 3,498 ± 67,363 μg/cm2.hour with a percentage content of 40,881%. Based on results, it concluded formulation used form microemulsion that was clear and stable. In the cumulative drug penetration test results, the penetration rate of microemulsions with virgin coconut oil carrier provides more penetration of piroxicam substances than microemulsions with palm oil carriers."